Bridgepoint Group (LON:BPT – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Berenberg Bank in a research note issued on Friday, Marketbeat reports. They currently have a GBX 360 target price on the stock. Berenberg Bank’s target price would suggest a potential upside of 13.35% from the stock’s previous close.
Separately, Citigroup lowered their price target on shares of Bridgepoint Group from GBX 415 to GBX 395 and set a “buy” rating on the stock in a report on Tuesday, April 14th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Bridgepoint Group presently has an average rating of “Buy” and a consensus target price of GBX 390.
View Our Latest Research Report on BPT
Bridgepoint Group Stock Up 0.8%
Bridgepoint Group Company Profile
Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.
See Also
- Five stocks we like better than Bridgepoint Group
- Telecom Earnings Reveal a Sector That Finally Looks Healthier
- Defense Earnings Show Readiness Now and Modernization Ahead
- Why Palantir Investors Aren’t Panicking While the Rest of AI Sells Off
- MarketBeat Week in Review – 07/20- 07/24
Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.
